Singapore- and San Francisco-based venture capital investor B Capital has backed the $20-million Series A funding in American life-science digital marketplace Labviva, according to an announcement.
Labviva, which uses AI to simplify and scale purchase processes, said its Series A financing round was anchored by Biospring Partners, a growth equity firm that invests in Life Sciences Technology. Aside from B Capital, the round was participated by Senator Investment Group and Glasswing Ventures.
